Free Trial

Alexandria Real Estate Equities (ARE) Competitors

Alexandria Real Estate Equities logo
$85.50 +0.76 (+0.90%)
As of 12:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ARE vs. MRNA, BXP, KRC, O, PLD, REXR, VICI, WELL, SLG, and HIW

Should you be buying Alexandria Real Estate Equities stock or one of its competitors? The main competitors of Alexandria Real Estate Equities include Moderna (MRNA), BXP (BXP), Kilroy Realty (KRC), Realty Income (O), Prologis (PLD), Rexford Industrial Realty (REXR), VICI Properties (VICI), Welltower (WELL), SL Green Realty (SLG), and Highwoods Properties (HIW).

Alexandria Real Estate Equities vs. Its Competitors

Alexandria Real Estate Equities (NYSE:ARE) and Moderna (NASDAQ:MRNA) are related companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

Alexandria Real Estate Equities has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500. Comparatively, Moderna has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500.

96.5% of Alexandria Real Estate Equities shares are owned by institutional investors. Comparatively, 75.3% of Moderna shares are owned by institutional investors. 1.1% of Alexandria Real Estate Equities shares are owned by insiders. Comparatively, 11.0% of Moderna shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Alexandria Real Estate Equities has a net margin of -0.33% compared to Moderna's net margin of -94.31%. Alexandria Real Estate Equities' return on equity of -0.05% beat Moderna's return on equity.

Company Net Margins Return on Equity Return on Assets
Alexandria Real Estate Equities-0.33% -0.05% -0.03%
Moderna -94.31%-25.96%-20.09%

Alexandria Real Estate Equities has higher earnings, but lower revenue than Moderna. Alexandria Real Estate Equities is trading at a lower price-to-earnings ratio than Moderna, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alexandria Real Estate Equities$3.12B4.75$322.95M-$0.13-657.72
Moderna$3.24B2.81-$3.56B-$7.53-3.10

Alexandria Real Estate Equities presently has a consensus target price of $97.17, indicating a potential upside of 13.64%. Moderna has a consensus target price of $42.88, indicating a potential upside of 83.56%. Given Moderna's higher probable upside, analysts clearly believe Moderna is more favorable than Alexandria Real Estate Equities.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alexandria Real Estate Equities
0 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.18
Moderna
4 Sell rating(s)
16 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.04

In the previous week, Moderna had 2 more articles in the media than Alexandria Real Estate Equities. MarketBeat recorded 17 mentions for Moderna and 15 mentions for Alexandria Real Estate Equities. Alexandria Real Estate Equities' average media sentiment score of 1.20 beat Moderna's score of 1.03 indicating that Alexandria Real Estate Equities is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alexandria Real Estate Equities
10 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Moderna
9 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

Alexandria Real Estate Equities beats Moderna on 9 of the 17 factors compared between the two stocks.

Get Alexandria Real Estate Equities News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARE vs. The Competition

MetricAlexandria Real Estate EquitiesREIT IndustryFinance SectorNYSE Exchange
Market Cap$14.78B$8.52B$12.60B$21.49B
Dividend Yield6.29%5.35%5.41%3.53%
P/E Ratio-657.5483.08244.0629.69
Price / Sales4.755.3430.6051.38
Price / Cash9.9718.9522.1224.51
Price / Book0.661.722.314.58
Net Income$322.95M$130.30M$1.01B$999.91M
7 Day Performance1.00%0.49%0.95%0.70%
1 Month Performance16.08%7.66%3.05%4.69%
1 Year Performance-29.85%-6.72%543.53%15.90%

Alexandria Real Estate Equities Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARE
Alexandria Real Estate Equities
4.0503 of 5 stars
$85.50
+0.9%
$97.17
+13.6%
-29.7%$14.78B$3.12B-657.54590Positive News
MRNA
Moderna
4.5104 of 5 stars
$24.09
-1.6%
$42.88
+78.0%
-68.1%$9.37B$3.06B-3.205,800Positive News
BXP
BXP
2.9213 of 5 stars
$72.63
+1.3%
$76.73
+5.6%
+0.0%$11.50B$3.41B2,421.84780Trending News
Dividend Cut
Analyst Downgrade
KRC
Kilroy Realty
4.0194 of 5 stars
$41.62
-0.3%
$38.55
-7.4%
+23.9%$4.92B$1.14B22.62260Positive News
O
Realty Income
3.996 of 5 stars
$58.75
+1.1%
$62.00
+5.5%
-3.9%$53.72B$5.27B57.04400Trending News
Dividend Increase
Analyst Forecast
PLD
Prologis
4.871 of 5 stars
$113.93
+1.1%
$121.83
+6.9%
-11.9%$105.76B$8.56B30.882,703Positive News
REXR
Rexford Industrial Realty
4.2815 of 5 stars
$41.46
+0.2%
$40.55
-2.2%
-13.2%$9.81B$936.41M30.71220Positive News
VICI
VICI Properties
4.6948 of 5 stars
$33.87
+1.1%
$35.55
+4.9%
-2.0%$36.12B$3.85B12.9820News Coverage
Positive News
Analyst Forecast
WELL
Welltower
4.5964 of 5 stars
$168.37
+0.6%
$175.00
+3.9%
+30.9%$112.61B$9.14B95.13510Positive News
SLG
SL Green Realty
2.9078 of 5 stars
$56.86
0.0%
$67.29
+18.3%
-5.5%$4.06B$886.27M-105.301,221News Coverage
Positive News
Analyst Upgrade
Gap Up
HIW
Highwoods Properties
3.5434 of 5 stars
$31.54
+1.4%
$32.00
+1.5%
+0.6%$3.41B$825.86M26.50340News Coverage
Positive News

Related Companies and Tools


This page (NYSE:ARE) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners